Literature DB >> 8726825

Pericholangitis in a rabbit colitis model induced by injection of muramyl dipeptide emulsified with a long-chain fatty acid.

K Kuroe1, Y Haga, O Funakoshi, K Kanazawa, I Mizuki, Y Yoshida.   

Abstract

Rabbit colitis has been induced by injection of muramyl dipeptide emulsified with a long-chain fatty acid. The muramyl dipeptide emulsion was injected submucosally at six portions of the rectum and colon, 10 cm proximal to the anus, using a flexible endoscope. Six rabbits were injected six times every 2 weeks and subsequently killed 2 weeks after the last injection. The histological changes of the colon that occurred in all 6 rabbits were mononuclear cell and histiocyte infiltration with sporadic eosinophils, transmural infiltration, and well-maintained goblet cell populations. These changes were different in degree. In 4 of 6 rabbits histological examination of the liver showed pericholangitis and periductal fibrosis mimicking the pericholangitis frequently seen in patients with inflammatory bowel disease. Fibrosis bridging between the portal and portal veins occurred in 2 rabbits, and noncaseating granuloma was seen in 1 rabbit. These histological changes in our model have led to the suggestion that continuous stimulation with bacterial cell wall fragments may be involved in chronic intestinal inflammation and extraintestinal manifestations such as pericholangitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726825     DOI: 10.1007/BF02355023

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

2.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

3.  The nature and origin of proliferated bile ductules in alcoholic liver disease.

Authors:  T Uchida; R L Peters
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

4.  The development of proliferating ductular structures in liver disease. An immunohistochemical study.

Authors:  S N Thung
Journal:  Arch Pathol Lab Med       Date:  1990-04       Impact factor: 5.534

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

Authors:  L Chedid; M Parant; F Parant; F Audibert; F Lefrancier; J Choay; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

8.  Role of intestinal microflora in chronic inflammation and ulceration of the rat colon.

Authors:  S Videla; J Vilaseca; F Guarner; A Salas; F Treserra; E Crespo; M Antolín; J R Malagelada
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

9.  Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis.

Authors:  K Emori; S Nagao; N Shigematsu; S Kotani; M Tsujimoto; T Shiba; S Kusumoto; A Tanaka
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

10.  Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats.

Authors:  S Yamada; M Ishii; L S Liang; T Yamamoto; T Toyota
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.